Abstract:: Basal cell carcinoma (BCC) is by far the most common human skin cancer. In Caucasians, BCCs account for around 90% of periocular malignancies. However, periocular BCCs are usually neglected due to their slow and painless growth, unless presenting complaints, e.g., large size, bleeding, recurrent infections of the tumor, or secondary symptoms resulting from adjacent structures involvement as epiphora, limited eye globe motility as well as globe displacement. Moreover, although the tumor can usually be cured with local excision, local recurrence can occur in up to 20% of eyelid BCC cases. Recurrent BCCs of the eyelid show a poorer overall prognosis than the primary ones. In addition, the management of advanced diseases, such as orbital or intracranial invasion as well as metastatic lesions, is challenging and often involves a multidisciplinary approach. In this paper, we reviewed the recent research progress of pathogenesis, clinical presentation, and therapeutics of periocular BCCs. We introduced the molecular pathogenesis of BCCs [multi-step ultraviolet (UV)-induced carcinogenesis model, genetic predisposition, and epigenetic changes], clinical classification, and tumor-node-metastasis (TNM) clinically stage of eyelid skin BCCs. We also emphasized the treatment of BCCs, i.e., surgical resection, oculoplastic reconstruction, and alternative therapies (radiation therapy, systemic therapy, topical therapy, and prophylactic therapy). In the end, we proposed that considering the possible iatrogenic damage to the surface of the eye by surgical excision, the treatment of periocular BCCs is recommended to be performed by or in the presence of an oculoplastic surgeon. (FFS), and fast paraffin (FP). Phan et al. performed a meta-analysis comparing recurrence rates of MMS, intraoperative FSE controlled excision, and wide local excision (WLE) with predetermined margins as well as paraffin section evaluation (37). The pooled recurrence rates for periocular BCCs following MMS, FSE, and WLE were 2.9% (95% CI, 1.9–4.4%, an average follow-up of 48.8±14.9 months), 1.9% (95% CI, 1.9–2.4%, an average follow-up of 70.7±48.0 months), and 5.9% (95% CI, 3.9–8.9%, an average follow-up of 49.2±29.3 months), respectively. Meta-regression analysis illustrated an insignificantly similar recurrence rate for MMS and FFS (P>0.05) and a significantly lower one in comparison to WLE without FSE.

Ocular sebaceous gland carcinoma: an update of the literature

Updates On The Clinical Diagnosis And Management Of Ocular Sebaceous Carcinoma: A Brief Review Of The Literature

Molecular landscape of eyelid sebaceous gland carcinoma: A comprehensive review

Eyelid/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis Based on 8th Edition American Joint Cancer Committee Classification

Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management

MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma

Eyelid sebaceous gland carcinoma: a protocol for a systematic review and meta-analysis of clinicopathological studies of prevalence

Sebaceous Carcinoma of the Ocular Region: The 2014 Professor Winifred Mao Lecture

Sebaceous carcinoma of the eyelid: a clinicopathological study

Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.

Treatment of sebaceous carcinoma with Mohs micrographic surgery versus wide local excision: a systematic review

Clinicopathologic Features And Prognostic Factors Of Malignant Eyelid Tumors

Recurrence in Eyelid Sebaceous Carcinoma: A Multicentric Study of 418 Patients.

Neoadjuvant Chemotherapy in Non-Metastatic Eyelid Sebaceous Gland Carcinoma: A Report in 10 Cases

Excision and Delayed Reconstruction With Paraffin Section Histopathological Analysis for Periocular Sebaceous Carcinoma

Periocular Basal Cell Carcinoma—current Treatment Concepts

Clinicopathological Analysis of 5146 Eyelid Tumours and Tumour-Like Lesions in an Eye Centre in South China, 2000–2018: a Retrospective Cohort Study

Spindle Cell Carcinoma of the Ocular Adnexa: A Case Report and Literature Review

Salivary gland carcinoma: Towards a more personalised approach

Intraepithelial growth pattern for eyelid sebaceous carcinoma: a cohort of 214 patients from a single institution

Extra-Ocular Sebaceous Carcinoma in Situ of the Arm of an Elder Male: An Unusual Presentation in an Atypical Location